Home › Funds › Deep Track Capital, LP › LBRX
Deep Track Capital, LP position in LBRX
LB PHARMACEUTICALS INC · Health Care
Deep Track Capital, LP reported holding 3,352,804 shares of LBRX (LB PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$108.8M, representing 1.62% of its reported portfolio and ranking #27 among its reported holdings. Deep Track Capital, LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's LBRX position evolved
Deep Track Capital, LP first disclosed a stake in LBRX in Q3 2025 at 3,352,804 shares (US$52.9M). The position peaked in Q2 2026 at 3,352,804 shares, worth US$108.8M. Across 4 filings, Deep Track Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,352,804 shares valued at US$108.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 3.35M | $52.94M | New |
| Q4 2025 | 3.35M | $74.63M | Hold |
| Q1 2026 | 3.35M | $82.68M | Hold |
| Q2 2026 | 3.35M | $108.82M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LBRX and 13F data
LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 110 other funds we track also report a position in LBRX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M), Commodore Capital LP (US$48.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LBRX
- RA CAPITAL MANAGEMENT, L.P. 2.21M sh · $71.68M · Q2 2026
- Trails Edge Capital Partners, LP 1.52M sh · $49.43M · Q2 2026
- Commodore Capital LP 1.50M sh · $48.68M · Q2 2026
- TCG Crossover Management, LLC 1.45M sh · $46.97M · Q2 2026
- Caligan Partners LP 1.44M sh · $46.67M · Q2 2026
- Spruce Street Capital LP 1.38M sh · $44.66M · Q2 2026
- Nantahala Capital Management, LLC 1.05M sh · $34.17M · Q2 2026
- Vivo Capital, LLC 800.00K sh · $25.96M · Q2 2026
- Nan Fung Group Holdings Ltd 630.66K sh · $20.47M · Q2 2026
- Logos Global Management LP 585.00K sh · $18.99M · Q2 2026
- GREAT POINT PARTNERS LLC 317.22K sh · $10.30M · Q2 2026
- HighVista Strategies LLC 211.51K sh · $6.86M · Q2 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held LBRX?
Deep Track Capital, LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Deep Track Capital, LP's current position in LBRX?
As of Q2 2026, Deep Track Capital, LP holds 3.35M shares of LBRX (LB PHARMACEUTICALS INC), valued at $108.82M, representing 1.62% of its reported portfolio and ranking #27.
Has Deep Track Capital, LP been buying or selling LBRX?
In the latest 13F filing (Q2 2026), Deep Track Capital, LP held unchanged its position in LBRX. The position peaked in Q2 2026 at 3.35M shares.
Which other funds hold LBRX?
Other major institutional holders of LBRX include RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, Commodore Capital LP, among 110 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.